Relation between telomerase activity, hTERT and telomere length for intracranial tumours

Oncology Reports

Volumn 18, Issue 6, 2007, Pages 1571-1576

  Maes, Lode ^a   Van Neste, L ^a   Van Damme, K ^a   Kalala, J P O ^b   De Ridder, L ^a   Bekaert, S ^a   Cornelissen, M ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Intracranial tumours; Telomerase; Telomere length

Indexed keywords

TELOMERASE;

ARTICLE; ASTROCYTOMA; BIOPSY; BRAIN TUMOR; ENZYMOLOGY; GENETICS; GLIOBLASTOMA; HUMAN; MENINGIOMA; METABOLISM; PATHOLOGY; TELOMERE; ULTRASTRUCTURE;

ASTROCYTOMA; BIOPSY; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; TELOMERASE; TELOMERE;

EID: 38449092894     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.6.1571     Document Type: Article

References (35)

1. Blackburn EH and Szostak JW: The molecular structure of centromeres and telomeres (review). Annu Rev Biochem 53: 163-164, 1984.
2. Blackburn EH: Structure and function of telomeres. Nature 350: 569-573, 1991.
3. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL and WU JR: A highly conserved repetitive DNA sequence (TTAGGG)n present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85: 6622-6626, 1988.
4. Nugent CI and Lundblad V: The telomerase reverse transcriptase: components and regulation. Genes Dev 12: 1073-1085, 1998. (Pubitemid 28194043)
5. Cong YS, Wright WE and Shay JW: Human telomerase and its regulation (review). Microbiol Mol Biol Rev 66: 407-425, 2002. (Pubitemid 35001137)
6. Hahn WC: Role of telomeres and telomerase in the pathogenesis of human cancer (review). J Clin Oncol 2: 2034-2043, 2003.
7. Maser RS and De Pinho RA: Connecting chromosomes, crisis and cancer. Science 297: 565-569, 2002.
8. Ulaner GA: Telomere maintenance in clinical medicine (review). Am J Med 117: 262-269, 2004.
9. Masutomi K, Kaneko S, Hayashi N, Yamashita T, Shirota Y, Kobayashi K and Murakami S: Telomerase activity reconstituted in vitro with purified human reverse transcriptase and human telomerase RNA component. J Biol Chem 274: 22568-22573, 2000. (Pubitemid 30621849)
10. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB, Taylor RD, Carlos R, Andrews WH, Wright WE, Shay JW, Harley CB and Morin GB: Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 17: 498-502, 1997. (Pubitemid 27518407)
11. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
12. Boldrini L, Pistolesi S, Gisfredi S, Ursino S, Lupi G, Caniglia M, Pingitori R, Basolo F, Parenti G and Fontanini G: Telomerase in intracranial meningiomas. Int J Mol Med 12: 943-947, 2003.
13. Chen HJ, Liang CL, Lu K, Lin JW and Cho CL: Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas. Cancer 89: 2092-2098, 2000.
14. Morii K, Tanaka R, Onda K, Tsumanuma I and Yoshimura J: Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas. Biochem Biophys Res Commun 239: 830-834, 1997. (Pubitemid 27504187)
15. Falchetti ML, Larocca LM and Pallini R: Telomerase in brain tumours (review). Childs Nerv Syst 18: 112-117, 2002.
16. Maes L, Lippens E, Kalala JP and De Ridder L: The hTERTprotein and Ki-67 labelling index in recurrent and non-recurrent meningiomas. Cell Prolif 38: 3-12, 2005. (Pubitemid 40229263)
17. Simon M, Park TW, Leuenroth S, Hans VH, Loning T and Schramm J: Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression. J Neurosurg 92: 832-840, 2000. (Pubitemid 30243932)
18. Maes L, Kalala JP, Cornelissen R and De Ridder L: Telomerase activity and hTERT protein expression in meningiomas: an analysis in vivo versus in vitro. Anticancer Res 26: 2295-2300, 2006. (Pubitemid 43980190)
19. Morin GB: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529, 1989.
20. Kalala JP, Maes L, Vandenbroecke C and De Ridder L: The hTERT protein as a marker for malignancy in meningiomas. Oncol Rep 13: 273-277, 2005.
21. Kleihues P and Cavenee WK: Pathology and genetics of the nervous system. In: World Health Organization Classification of Tumours. Kleihues P and Cavenee WK (eds). IARC Press, Lyon, 2000.
22. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW and Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114-10118, 1992.
23. Bekaert S, van Pottelbergh I, De Meyer T, Zmierczak H, Kaufman JM, van Oostveldt P and Goemaere S: Telomere length versus hormonal and one mineral status in healthy elderly men. Mech Ageing Dev 126: 1115-1122, 2005. (Pubitemid 41253863)
24. Cerezo A, Stark HJ, Moshir S and Boukamp P: Constitutive overexpression of human telomerase reverse transcriptase but not c-myc blocks terminal differentiation in human HaCaT skin keratinocytes. J Invest Dermatol 121: 110-119, 2003. (Pubitemid 36900462)
25. Hahn WC and Weinberg RA: Rules for making human tumour cells (review). N Engl J Med 347: 1593-1603, 2002. (Pubitemid 35315841)
26. Gertler R, Rosenberg R, Stricker D, Friederichs S, Hoos A, Werner M, Ulm K, Holzmann B, Nekarda H and Siewert JR: Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol 22: 1807-1814, 2004. (Pubitemid 41095170)
27. Counter CM, Avilion AA, Le Feuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929, 1992.
28. Wu YL, Dudognon C, Nguyen E, Hillion J, Pendino F, Tarkanyi I, Aradi J, Lanotte M, Tong JH, Chen GQ and Segal-Bendirdjian E: Immunodetection of human telomerase reverse transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths. J Cell Sci 119: 2797-2806, 2006. (Pubitemid 44184016)
29. Engelhardt M, Drullinsky P, Guillem J and Moore MA: Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 3: 1931-1941, 1997. (Pubitemid 27505118)
30. Jiang WQ, Zhong ZH, Henson JD, Neumann AA, Chang AC and Reddel RR: Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/ RAD50/NBS1 complex. Mol Cell Biol 25: 2708-2721, 2005. (Pubitemid 40381634)
31. Muntoni A and Reddel RR: The first molecular details of ALT in human tumour cells (review). Hum Mol Genet 14: R191-R196, 2005. (Pubitemid 41631887)
32. Hakin-Smith V, Jellinek DA, Levy D, Carroll T, Teo M, Timperley WR, McKay MJ, Reddel RR and Royds JA: Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 361: 836-838, 2003. (Pubitemid 36331849)
33. Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA, Wharton SB, Jellinek DA, Arbuckle SM, Robinson BG, Learoyd DL, Stalley PD, Bonar SF, Yu D, Pollock RE and Reddel RR: A robust assay for alternative lengthening of telomeres in tumours shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res 11: 217-225, 2005. (Pubitemid 40075798)
34. Hiyama E, Hiyama K, Yokoyama T, Ichikawa T and Matsuura Y: Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn J Cancer Res 83: 159-164, 1992.
35. Hiraga S, Ohnishi T, Izumoto S, Miyahara E, Kanemura Y, Matsumura H and Arita N: Telomerase activity and alterations in telomere length in human brain tumours. Cancer Res 58: 2117-2125, 1998. (Pubitemid 28232897)